Kathleen Otto-Rosenblum, CEO of BioNTX [Photo: BioNTX]
Advanced Therapies Week 2025—a conference focused on the latest innovations in cell and gene therapies, regenerative medicine, and other biotechnologies—attracted industry leaders, researchers, and visionaries to Dallas' Kay Bailey Hutchison Convention Center in late January. Organized by London-based Phacilitate, the 4-day conference acted as a "collaborative hub" showcasing the intersection of cutting-edge science, transformative healthcare solutions, and dynamic regional collaboration.